Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	95.28	-4.90	-103.77
Graham Fair Price	40.23	0.51	0.36
PEG	-83.08	< 0.005	0.02
Price/Book	-9.23	0.11	0.12
Price/Cash Flow	65.63	-3.91	-11.37
Prices/Earnings	54.62	-0.40	-0.89
Price/Sales	-54.62	2.07	4.57
Price/FCF	65.63	-3.91	-11.37
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-1060.01	-2.38	-0.21
Operating Margin	-192.00	-2.85	-0.98
ROA	-100.00	-0.06	-0.03
ROE	-0.03	-0.07	-100.00
ROIC	-0.02	-0.07	-208.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	< 0.005	375.91
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.44	-4.84	1005.70
EPS QOQ	0.36	-0.98	168.24
FCF QOQ	-1.83	-1.64	10.48
Revenue QOQ	-0.60	1.00	65.75
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	29.22	5.21	-82.17
Days Sales Outstanding (DSO)	86.94	62.61	-27.99
Inventory Turnover	3.08	17.28	460.99
Debt/Capitalization	0.35	0.34	-1.68
Quick Ratio	1.29	1.51	16.41
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.42	0.41	-0.84
Cash	0.03	0.03	4.28
Capex	< 0.005	< 0.005	0.84
Free Cash Flow	< 0.005	-0.01	-161.85
Revenue	0.01	0.02	98.31
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.80	1.80	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-82.59	-3.97	95.19
Naive Interpretation	Member

06 - Financial Health · Weak

Rating